Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1-3
pubmed:dateCreated
1988-12-8
pubmed:abstractText
One of our major aims was to find ways to utilize outdated or virus-contaminated blood. Pyridoxylated hemoglobin (PLP-Hb), a possible substitute for red cells as an artificial oxygen carrier was prepared from outdated human blood. By conjugation with polyethylene glycol (PEG), the biological half life was increased about 3 folds at 82% blood replacement in rats without significant side effects in vivo or in vitro. We next tried to prepare virus-free PEG-PLP-Hb from HBV or HTLV-I positive blood. A considerable amount of HBV (Dane particles) could be removed from HBV-positive red cells by washing and during the preparation of PEG-PLP-Hb. When the hemoglobin preparations containing Dane particles were filtered through a porous cellulose filter, BMM-30 (30 nm pore size, Asahi Chemical Industry Co., Ltd., Osaka, Japan), HBV-DNA in the filtered fractions became less than 0.33% of the initial amount. More than 96% of blood leukocytes could be removed with a leukocyte removal filter, Sepacell R-500 (Asahi Medical Co., Ltd., Tokyo, Japan). The leukocytes collected from filtrated fractions of HTLV-I positive blood did not survive beyond 3 days. Since transmission of HTLV-I occurs by cell to cell contact and is rare in cell-Free condition, it is unlikely that the PLP-Hb prepared from HTLV-I positive blood which is deprived of leukocytes transmits HTLV-I infection.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0890-5533
pubmed:author
pubmed:issnType
Print
pubmed:volume
16
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
113-21
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:3179462-Animals, pubmed-meshheading:3179462-Blood, pubmed-meshheading:3179462-Blood Component Removal, pubmed-meshheading:3179462-Blood Substitutes, pubmed-meshheading:3179462-Cell Separation, pubmed-meshheading:3179462-Centrifugation, Density Gradient, pubmed-meshheading:3179462-Chemical Phenomena, pubmed-meshheading:3179462-Chemistry, pubmed-meshheading:3179462-Chemistry, Physical, pubmed-meshheading:3179462-DNA, Viral, pubmed-meshheading:3179462-Erythrocytes, pubmed-meshheading:3179462-Exchange Transfusion, Whole Blood, pubmed-meshheading:3179462-Filtration, pubmed-meshheading:3179462-HIV, pubmed-meshheading:3179462-Half-Life, pubmed-meshheading:3179462-Hemoglobins, pubmed-meshheading:3179462-Hepatitis B Surface Antigens, pubmed-meshheading:3179462-Hepatitis B virus, pubmed-meshheading:3179462-Humans, pubmed-meshheading:3179462-Leukocytes, pubmed-meshheading:3179462-Male, pubmed-meshheading:3179462-Physicochemical Phenomena, pubmed-meshheading:3179462-Polyethylene Glycols, pubmed-meshheading:3179462-Pyridoxal Phosphate, pubmed-meshheading:3179462-Rats
pubmed:year
1988
pubmed:articleTitle
Preparation of virus-free pyridoxylated hemoglobin from the blood of HBV or HTLV-I healthy carriers.
pubmed:affiliation
Research Division, Hokkaido Red Cross Blood Center, Sapporo, Japan.
pubmed:publicationType
Journal Article